AstraZeneca Slams Actavis With IP Suit Over Diabetes Drug
Swedish pharmaceutical giant AstraZeneca AB hit Actavis Inc with a suit in Delaware federal court Friday, to halt the sale of a generic version of a diabetes drug that AstraZeneca claims...To view the full article, register now.
Already a subscriber? Click here to view full article